Andy Lundin, Author at Gastroenterology Advancements

Addressing the Challenges of Stool-Based Colorectal Cancer Screening

Posted by Andy Lundin | Jul 31, 2024 | Non-Invasive Tests |

Stool-based colorectal cancer screening tests, such as FIT and multi-target stool DNA tests, offer a non-invasive alternative to colonoscopy.

Posted by Andy Lundin | Jul 31, 2024 | Pathology |

Molecular pathology is revolutionizing the diagnosis and treatment of pancreatic cancer, offering new opportunities for precision medicine.

Posted by Andy Lundin | Jul 31, 2024 | Genetic Testing |

Pharmacogenomics, the study of how genes affect a person’s response to drugs, is changing the landscape of gastrointestinal cancer treatment.

Posted by Andy Lundin | Jul 31, 2024 | Laboratory Tests |

Proteomics is transforming the way clinicians approach GI disorders, offering new insights into disease mechanisms and early detection.

Mindful eating and stress reduction techniques play a key role in maintaining optimal GI health by fostering a healthy gut-brain connection.